ASO-4733

N/A

Report date: 2026/01/19 17:25:27
NME

Base Information

Drug NameASO-4733
Drug Alias NameASO-4733ASO4733
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSynaptotagmin-13 gene transference
TargetsSynaptotagmin-13
Therapy Area/IndicationsStomach NeoplasmsPeritoneal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsPeritoneal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A